Back to resultsMethamphetamine Abuse Treatment in Patients With AIDS - 1
Primary Purpose
Substance-Related Disorders
Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Desipramine
Sponsored by
About this trial
This is an interventional treatment trial for Substance-Related Disorders focused on measuring methamphetamine dependence
Eligibility Criteria
Please contact site for information.
Sites / Locations
- Friends Research Institute
Outcomes
Primary Outcome Measures
Craving
Retention
Depression
Methamphetamine use
Anxiety and Depression
ASI Scales (7)
AIDS medical care engagement
High risk sexual behaviors
Mood indicators
Secondary Outcome Measures
Full Information
NCT ID
NCT00000321
First Posted
September 20, 1999
Last Updated
January 11, 2017
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
Friends Research Institute, Inc.
1. Study Identification
Unique Protocol Identification Number
NCT00000321
Brief Title
Methamphetamine Abuse Treatment in Patients With AIDS - 1
Official Title
Methamphetamine Abuse Pharmacology in Patients With AIDS
Study Type
Interventional
2. Study Status
Record Verification Date
October 1996
Overall Recruitment Status
Completed
Study Start Date
October 1996 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
December 2001 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
Friends Research Institute, Inc.
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to evaluate the efficacy of desipramine, sertraline, and placebo on methamphetamine dependent gay men with AIDS.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Substance-Related Disorders
Keywords
methamphetamine dependence
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Enrollment
0 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Desipramine
Primary Outcome Measure Information:
Title
Craving
Title
Retention
Title
Depression
Title
Methamphetamine use
Title
Anxiety and Depression
Title
ASI Scales (7)
Title
AIDS medical care engagement
Title
High risk sexual behaviors
Title
Mood indicators
10. Eligibility
Sex
Male
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Frank Gawin, M.D.
Organizational Affiliation
Friends Research Institute, Inc.
Official's Role
Principal Investigator
Facility Information:
Facility Name
Friends Research Institute
City
Los Angeles
State/Province
California
ZIP/Postal Code
90025
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Methamphetamine Abuse Treatment in Patients With AIDS - 1
We'll reach out to this number within 24 hrs